STAAR Surgical expects Q2 net sales above $90 million
STAA•Preliminary Q2 sales outlook tops $90 million
STAAR Surgical forecast preliminary Q2 2026 net sales above $90 million, versus $44.3 million a year earlier.
The outlook was supported by sequential growth in China, solid Asia-Pacific gains, and double-digit growth in the Americas.
EMEA sales fell a low single-digit %, citing Middle East turmoil; excluding the Middle East, EMEA posted double-digit growth.
Geopolitical and macroeconomic headwinds hurt the Middle East and parts of EMEA and Asia-Pacific; prolonged pressure could weigh on growth.
ERP implementation created operational challenges; remaining system issues are targeted for resolution in Q3.
